This topic contains a solution. Click here to go to the answer

Author Question: Vitamin _____ status may be affected by steatorrhea related to liver damage. a. C b. A c. B12 d. ... (Read 181 times)

Redwolflake15

  • Hero Member
  • *****
  • Posts: 569
Vitamin _____ status may be affected by steatorrhea related to liver damage.
 a. C b. A
  c. B12 d. B6

Question 2

John has severe ascites due to advanced cirrhosis. He is scheduled to undergo a procedure that will use a surgical puncture to draw excess fluid out of his abdomen. What is this procedure called?
 a. Shock-wave lithotripsy b. Paracentesis
  c. Peritoneovenous shunt d. Parenteral support



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Joc

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

b

Answer to Question 2

b




Redwolflake15

  • Member
  • Posts: 569
Reply 2 on: Aug 21, 2018
YES! Correct, THANKS for helping me on my review


isabelt_18

  • Member
  • Posts: 342
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library